IBA Reduces Energy-related Costs of Proton Therapy

June 1, 2015 — IBA (Ion Beam Applications S.A) announced the release of an exclusive feature that reduces the power consumption of IBA proton therapy 230 MeV isochronous cyclotron (C230) by more than 30 percent. This unique feature helps reduce the overall cost of proton therapy, making it ever more accessible to patients worldwide.

First measurements at the Institut Curie’s Orsay Proton Therapy Center (France) show that the power consumption of the cyclotron has been lowered by an average of 30 percent over a month’s period.

IBA reported that the new feature can be retrofitted to all of its existing systems, helping customers significantly reduce their energy bills, and therefore the overall operation costs of proton therapy centers.

For more information: www.iba-worldwide.com